Methods and devices for preparation of ultrasound contrast agents
Provided herein are methods and devices for identifying and/or distinguishing UCA formulations and specifically activating such formulations to produce UCA suitable for in vivo use.
1. A shaking device comprising:
a holder configured to hold a vial containing an ultrasound contrast agent (UCA) lipid formulation;
a detector configured to identify a sample type, wherein the sample type is an aqueous UCA lipid formulation or a non-aqueous UCA lipid formulation, and wherein the detector is an RFID reader, a barcode scanner, a color scanner, or a microchip reader;
a memory, wherein two or more pre-set options are stored in the memory, wherein the two or more pre-set options each define a period of time and/or a shaking rate; and
a processor configured to select a period of time and/or shaking rate from the two or more pre-set options based on the identified sample type,
wherein the device is configured to activate the identified sample type at the selected period of time and/or selected shaking rate.
2. The device of claim 1 , wherein when the sample type is identified as a non-aqueous UCA lipid formulation, the device automatically selects about 45 seconds and/or about 5000 shaking motions per minute for activating the UCA lipid formulation.
3. The device of claim 1 , wherein when the sample type is identified as an aqueous UCA lipid formulation, the device automatically selects about 45 seconds and/or about 4500 shaking motions per minute for activating the UCA lipid formulation.
4. The device of claim 1 , wherein the device imparts a reciprocating motion, a revolution, or a figure of 8 motion to activate the identified sample type.
5. The device of claim 1 , wherein the detector is an RFID reader.
6. The device of claim 1 , wherein the detector is a barcode scanner.
7. The device of claim 1 , wherein the detector is a color scanner.
8. The shaking device of claim 1 , wherein when the sample type is identified, the shaking device automatically selects a period of time from at least two pre-set periods of time.
9. The shaking device of claim 1 , wherein when the sample type is identified, the shaking device automatically selects a shaking rate from at least two pre-set shaking rates.
10. The shaking device of claim 9 , wherein one of the at least two pre-set shaking rates is about 4500 or about 5000 shaking motions per minute.
11. The device of claim 1 , wherein when the sample type is identified as a non-aqueous UCA lipid formulation, the device selects pre-set options of 45 seconds and about 5000 shaking motions per minute for activating the sample type.
12. The device of claim 1 , wherein when the sample type is identified as an aqueous UCA lipid formulation, the device selects pre-set options of 45 seconds and 4530 shaking motions per minute for activating the sample type.
13. The device of claim 1 , wherein the two or more pre-set options comprise a period of time that is 45 seconds, a first shaking rate that is 4530 shaking motions per minute, and a second shaking rate that is about 5000 shaking motions per minute.